Consistent HbA1c and body weight reduction with semaglutide independent of diabetes duration: SUSTAIN 1-5 and 7 patient-level meta-analysis

被引：0
|
作者：
Madsbad, S. [1 ]
Bain, S. C. [2 ]
Chaykin, L. [3 ]
Luedemann, J. [4 ]
Furberg, J. Kjaerulff [5 ]
Larsen, J. Rask [5 ]
Yildirim, E. [5 ]
Rosenstock, J. [6 ]
机构：
[1] Univ Copenhagen, Hvidovre Hosp, Copenhagen, Denmark
[2] Swansea Univ, Sch Med, Swansea, W Glam, Wales
[3] Meridien Res, Bradenton, FL USA
[4] Diabet Ctr & Ctr Clin Studies, Diabet Falkensee, Falkensee, Germany
[5] Novo Nordisk AS, Soborg, Denmark
[6] Dallas Diabet Res Ctr Med City, Dallas, TX USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
740
引用
收藏
页码：S360 / S361
页数：2
相关论文
共 50 条
  • [31] Effect of once-weekly semaglutide 2 mg vs 1 mg on HbA1c and body weight by baseline demographic subgroups: SUSTAIN FORTE post hoc analysis
    Frias, J. P.
    Bardtrum, L.
    Hansen, Y.
    Lingvay, I.
    Macura, S.
    Tentolouris, N.
    Buse, J. B.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S289 - S290
  • [32] HbA1c reduction with tirzepatide in people with type 2 diabetes: a mediation analysis using body weight loss as a factor
    Vilsboll, T.
    Nicolay, C.
    Malecki, M.
    Thieu, V. Thuyanh
    Chivukula, K.
    Kiljanski, J.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S324 - S325
  • [33] Prediction of Incident Diabetes by Measurements of both HbA1C and Fasting Plasma Glucose in Comparison With Use of HbA1c or FPG Alone: A Meta-Analysis
    Kodama, Satoru
    Horikawa, Chika
    Tajima, Ryoko
    Fujihara, Kazuya
    Yoshizawa, Sakiko
    Ibe, Yoko
    Hirasawa, Reiko
    Shimano, Hitoshi
    Saito, Kazumi
    Sone, Hirohito
    DIABETES, 2012, 61 : A368 - A368
  • [34] Baseline HbA1c predicts the likelihood of reaching the 7.0% HbA1c target with structured titration of add-on insulin glargine: patient-level analysis of 12 studies in type 2 diabetes mellitus
    Zhou, R.
    Vlajnic, A. A.
    Orloff, D.
    Rosenstock, J.
    Riddle, M.
    DIABETOLOGIA, 2009, 52 : S350 - S350
  • [35] Once-Weekly Semaglutide Reduces HbA1c and Body Weight in Patients with Type 2 Diabetes Regardless of Background Common OAD: a Subgroup Analysis from SUSTAIN 2–4 and 10
    Matthew Capehorn
    Yasmin Ghani
    Charlotte Hindsberger
    Pierre Johansen
    Esteban Jódar
    Diabetes Therapy, 2020, 11 : 1061 - 1075
  • [36] HbA1C Variability and the Risk of Renal Status Progression in Diabetes Mellitus: A Meta-Analysis
    Cheng, Dongsheng
    Fei, Yang
    Liu, Yumei
    Li, Junhui
    Xue, Qin
    Wang, Xiaoxia
    Wang, Niansong
    PLOS ONE, 2014, 9 (12):
  • [37] HbA1c as screen tool for detection of diabetes mellitus in Chinese adults: A meta-analysis
    陈静
    China Medical Abstracts(Internal Medicine), 2018, 35 (02) : 79 - 79
  • [38] Impact of baseline characteristics and beta-cell function on the efficacy and safety of subcutaneous once-weekly semaglutide: A patient-level, pooled analysis of the SUSTAIN 1-5 trials
    Aroda, Vanita R.
    Capehorn, Matthew S.
    Chaykin, Louis
    Frias, Juan P.
    Lausvig, Nanna L.
    Macura, Stanislava
    Luedemann, Jorg
    Madsbad, Sten
    Rosenstock, Julio
    Tabak, Omur
    Tadayon, Sayeh
    Bain, Stephen C.
    DIABETES OBESITY & METABOLISM, 2020, 22 (03): : 303 - 314
  • [39] Effects of motivational interviewing on HbA1c and depression among cases with type 1 diabetes: a meta-analysis
    Yanyan Chen
    Yao Tian
    Xiaohong Sun
    Fulian Zhang
    Xiao Huang
    International Journal of Diabetes in Developing Countries, 2022, 42 : 191 - 202
  • [40] Effects of motivational interviewing on HbA1c and depression among cases with type 1 diabetes: a meta-analysis
    Chen, Yanyan
    Tian, Yao
    Sun, Xiaohong
    Zhang, Fulian
    Huang, Xiao
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2022, 42 (02) : 191 - 202
12345